Caspian Therapeutics Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $50M

  • Investors
  • 6

Caspian Therapeutics General Information

Description

Developer of menin inhibitors designed to restore insulin producing capacity. The company utilizes selective expansion and improved function of pancreatic cells, enabling diabetes patients to restore natural insulin production and improve metabolic health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4930 Directors Place
  • Suite 500
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4930 Directors Place
  • Suite 500
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caspian Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 09-Sep-2026 $50M Completed Generating Revenue
1. Spin-Off Completed Generating Revenue
To view Caspian Therapeutics’s complete valuation and funding history, request access »

Caspian Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Caspian Therapeutics’s complete cap table history, request access »

Caspian Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVF Partners Hedge Fund Minority
Invus (Private Equity) PE/Buyout Minority
Kura Oncology Corporation Minority
Lilly USA Corporation Minority
Montanova Capital Hedge Fund Minority
You’re viewing 5 of 6 investors. Get the full list »

Caspian Therapeutics FAQs

  • When was Caspian Therapeutics founded?

    Caspian Therapeutics was founded in 2026.

  • Where is Caspian Therapeutics headquartered?

    Caspian Therapeutics is headquartered in San Diego, CA.

  • What industry is Caspian Therapeutics in?

    Caspian Therapeutics’s primary industry is Drug Discovery.

  • Is Caspian Therapeutics a private or public company?

    Caspian Therapeutics is a Private company.

  • What is the current valuation of Caspian Therapeutics?

    The current valuation of Caspian Therapeutics is .

  • What is Caspian Therapeutics’s current revenue?

    The current revenue for Caspian Therapeutics is .

  • How much funding has Caspian Therapeutics raised over time?

    Caspian Therapeutics has raised $50M.

  • Who are Caspian Therapeutics’s investors?

    BVF Partners, Invus (Private Equity), Kura Oncology, Lilly USA, and Montanova Capital are 5 of 6 investors who have invested in Caspian Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process